Clinical Trials Sponsored by Syndax Pharmaceuticals, Inc.
Total 5032 results
-
Syndax PharmaceuticalsRecruiting
-
Syndax PharmaceuticalsAvailable
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseKorea, Republic of, United States, Spain, Taiwan, France, Singapore, Belgium, Germany, Italy, Canada, Israel, Australia, United Kingdom, Greece, Poland, Portugal
-
Syndax PharmaceuticalsActive, not recruitingChronic Graft-versus-host-diseaseUnited States
-
Syndax PharmaceuticalsCompletedCarcinoma, Non-Small Cell Lung | Non-Small-Cell Lung CarcinomaUnited States
-
Syndax PharmaceuticalsTerminatedCOVID | ARDS | Coronavirus | Cytokine Storm | Cytokine Release SyndromeUnited States
-
Syndax PharmaceuticalsTerminatedHodgkin's LymphomaUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteer | Drug InteractionUnited States
-
Syndax PharmaceuticalsWithdrawn
-
Syndax PharmaceuticalsTerminated
-
Syndax PharmaceuticalsRecruitingAcute Myeloid LeukemiasUnited States
-
Syndax PharmaceuticalsRecruitingColorectal Cancer | Solid TumorsUnited States
-
Syndax PharmaceuticalsRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute LeukemiaUnited States, Israel, Spain, Australia, Netherlands, Germany, Canada, France, Italy, Lithuania
-
Syndax PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Undifferentiated Leukemia | Relapsed/Refractory Leukemias | Mixed Phenotype Acute LeukemiaUnited States, Canada
-
Syndax PharmaceuticalsTerminatedNon Small Cell Lung CancerUnited States
-
Syndax PharmaceuticalsCompletedSolid Tumor | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | Metastatic TumorUnited States
-
Syndax PharmaceuticalsCompleted
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Syndax PharmaceuticalsCompletedNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Endocrine Gland Neoplasms | Breast Neoplasms | Breast Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Bronchial Neoplasms | Solid... and other conditionsUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | Lung Cancer | Non Small Cell Lung Cancer (NSCLC) | Estrogen Receptor Breast CancerUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedRenal Impairment | Healthy VolunteerUnited States
-
Syndax PharmaceuticalsDevPro BiopharmaRecruitingIdiopathic Pulmonary FibrosisAustralia
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; Syndax PharmaceuticalsRecruiting
-
Roberto PiliGenentech, Inc.; Syndax PharmaceuticalsSuspendedMetastatic Cancer | Renal CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterSyndax PharmaceuticalsCompletedMelanomaUnited States
-
University of VirginiaSyndax PharmaceuticalsCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Syndax PharmaceuticalsRoche Pharma AGCompletedBreast CancerUnited States, Georgia
-
M.D. Anderson Cancer CenterSyndax PharmaceuticalsNot yet recruitingLeukemia | HOX GeneUnited States
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCCompletedNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Endocrine Gland Neoplasms | Breast Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Bronchial Neoplasms | Solid Tumors | Renal...United States
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCCompletedMelanoma | Non-Small Cell Lung Cancer | Mismatch Repair-Proficient Colorectal CancerUnited States
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
St. Jude Children's Research HospitalSyndax PharmaceuticalsRecruitingRefractory Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Relapsed Acute Myeloid LeukemiaUnited States
-
Syndax PharmaceuticalsPfizer; Merck KGaA, Darmstadt, GermanyCompletedStudy of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Synta Pharmaceuticals Corp.CompletedSolid TumorsUnited States
-
Synta Pharmaceuticals Corp.Completed
-
Synta Pharmaceuticals Corp.CompletedAdvanced or Metastatic Solid TumorsUnited States
-
Synta Pharmaceuticals Corp.Completed
-
Synta Pharmaceuticals Corp.CompletedCrohn's DiseaseUnited States, Canada
-
Synta Pharmaceuticals Corp.CompletedSoft Tissue SarcomaUnited States, Canada
-
Synta Pharmaceuticals Corp.Completed
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IVUnited States, Belgium, Bosnia and Herzegovina, Canada, Croatia, Czech Republic, Germany, Poland, Romania, Russian Federation, Serbia, Spain, United Kingdom
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States, Canada
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Synta Pharmaceuticals Corp.CompletedActive, Moderate to Severe Rheumatoid ArthritisNetherlands